Gene Signature-Based Prognostic Model for Acute Myeloid Leukemia: The Role of BATF, EGR1, PD-1, PD-L1, and TIM-3.

Int J Med Sci · 2025 · PMC11983303 · PMID 40225861

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a notable trendno p-value reported

did not reach statistical significanceno p-value reported

Analysis of the TCGA cohort showed that patients with elevated EGR1 expression exhibited a notable trend toward favorable prognosis, although this trend did not reach statistical significance ( Figure S1 C).

also in 2,380 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Gene Signature-Based Prognostic Model for Acute Myeloid Leukemia: The Role of &lt;i&gt;BATF&lt;/i&gt;, &lt;i&gt;EGR1&lt;/i&gt;, &lt;i&gt;PD-1&lt;/i&gt;, &lt;i&gt;PD-L1&lt;/i&gt;, and &lt;i&gt;TIM-3&lt;/i&gt;.

The sentences

Gene Signature-Based Prognostic Model for Acute Myeloid Leukemia: The Role of <i>BATF</i>, <i>EGR1</i>, <i>PD-1</i>, <i>PD-L1</i>, and <i>TIM-3</i>.